These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34166382)

  • 1. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
    Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
    PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation and calibration of risk equations for prediction of diabetic kidney diseases among patients with type 2 diabetes in Taiwan.
    Su HY; Nguyen TTD; Lin WH; Ou HT; Kuo S
    Cardiovasc Diabetol; 2024 Oct; 23(1):357. PubMed ID: 39385193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach.
    Yang CT; Chong KS; Wang CC; Ou HT; Kuo S
    Cardiovasc Diabetol; 2024 Jul; 23(1):244. PubMed ID: 38987773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
    Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
    Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Prediction Scores for Mortality, Cerebrovascular, and Heart Disease Among Chinese People With Type 2 Diabetes.
    Quan J; Pang D; Li TK; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Lau ZY; Tan KB; Leung GM
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5823-5830. PubMed ID: 31287503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Bertoni AG; Correa A; Mwasongwe S; Yudkin JS
    Diabetes Care; 2018 Mar; 41(3):586-595. PubMed ID: 29269511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Yudkin JS
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):788-798. PubMed ID: 28803840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study.
    Zhang X; Wu H; Fan B; Shi M; Lau ESH; Yang A; Chow E; Kong APS; Chan JCN; Ma RCW; Luk AOY
    PLoS Med; 2022 Jul; 19(7):e1004045. PubMed ID: 35862297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.
    Keng MJ; Leal J; Mafham M; Bowman L; Armitage J; Mihaylova B
    Value Health; 2022 Mar; 25(3):435-442. PubMed ID: 35227456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.
    Hayes AJ; Leal J; Gray AM; Holman RR; Clarke PM
    Diabetologia; 2013 Sep; 56(9):1925-33. PubMed ID: 23793713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equations.
    Lundqvist A; Steen Carlsson K; Johansen P; Andersson E; Willis M
    PLoS One; 2014; 9(10):e110235. PubMed ID: 25310196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the Hong Kong Chinese non-laboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care.
    Cheng WH; Dong W; Tse ET; Wong CK; Chin WY; Bedford LE; Fong DY; Ko WW; Chao DV; Tan KC; Lam CL
    J Diabetes Investig; 2024 Sep; 15(9):1317-1325. PubMed ID: 39212338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90).
    Leal J; Alva M; Gregory V; Hayes A; Mihaylova B; Gray AM; Holman RR; Clarke P
    Diabet Med; 2021 Oct; 38(10):e14656. PubMed ID: 34297424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
    Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
    Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a diabetes mellitus and prediabetes risk prediction function for case finding in primary care in Hong Kong: a cross-sectional study and a prospective study protocol paper.
    Dong W; Cheng WHG; Tse ETY; Mi Y; Wong CKH; Tang EHM; Yu EYT; Chin WY; Bedford LE; Ko WWK; Chao DVK; Tan KCB; Lam CLK
    BMJ Open; 2022 May; 12(5):e059430. PubMed ID: 35613775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrovascular Risk Equations Based on the CANVAS Program.
    Willis M; Asseburg C; Slee A; Nilsson A; Neslusan C
    Pharmacoeconomics; 2021 Apr; 39(4):447-461. PubMed ID: 33580867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts.
    Pagano E; Konings SRA; Di Cuonzo D; Rosato R; Bruno G; van der Heijden AA; Beulens J; Slieker R; Leal J; Feenstra TL
    Diabetes Obes Metab; 2021 May; 23(5):1084-1091. PubMed ID: 33377255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry.
    Yang X; So WY; Kong AP; Ho CS; Lam CW; Stevens RJ; Lyu RR; Yin DD; Cockram CS; Tong PC; Wong V; Chan JC
    Diabetes Care; 2007 Jan; 30(1):65-70. PubMed ID: 17192335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.